Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

0.26USD
15 Jan 2019
Change (% chg)

-- (--)
Prev Close
$0.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
331,393
52-wk High
$2.89
52-wk Low
$0.18

Select another date:

Thu, Sep 6 2018

BRIEF-Novartis Receives Health Canada Approval Of Its Car-T Cell Therapy, Kymriah I

* NOVARTIS RECEIVES HEALTH CANADA APPROVAL OF ITS CAR-T CELL THERAPY, KYMRIAH™ (TISAGENLECLEUCEL)I

Select another date: